Introduction
TIF (Transoral Incisionless Fundoplication) treats GERD by recreating, from the inside, a version of what surgeons achieve with a fundoplication — wrapping the upper part of the stomach partially around the lower esophagus to reinforce the natural barrier against reflux. Using a specialized device, this is done entirely through the mouth, with no external incisions, and includes reducing a small hiatal hernia if one is present as part of the same procedure.
Is TIF safe, and does it work?
Yes, and this is genuinely well-supported by strong evidence, including the kind of rigorous trials that carry real weight — randomized, sham-controlled studies. A meta-analysis pooling 18 studies and 963 patients, including 5 randomized controlled trials, found patients receiving TIF were more than twice as likely to respond well compared to those on medication alone or a sham procedure. A large prospective multicenter study found 94% of patients achieved clinical success within a year. Durability has been demonstrated out to 9 years of follow-up in one long-term series, with sustained symptom improvement maintained. Safety is also strong: pooled data shows a serious adverse event rate of around just 1%. The section further down this page, ‘The evidence in more detail,’ has the specific study data.
Who is a candidate for TIF
- Confirmed GERD, diagnosed through endoscopy and manometry
- Generally suited to patients with a body mass index under 35
- Generally suited to patients with a hiatal hernia under 2cm — larger hernias are typically not appropriate for this specific technique
- Patients who prefer to avoid surgical fundoplication, or aren't ideal candidates for it
What to expect: before, during, and after
- Before: upper GI endoscopy and esophageal manometry to confirm the diagnosis and assess suitability, including hiatal hernia size
- During: performed under sedation; the device creates the partial wrap and, if present, reduces a small hiatal hernia in the same procedure
- After: some throat discomfort or mild difficulty swallowing for a few days is common and temporary; most patients resume normal diet within days
- Follow-up: symptom review, typically with the goal of reducing or stopping regular reflux medication if the procedure is successful
The evidence in more detail
This section is for anyone who wants the specific research behind the summary above — it's not necessary reading to understand the basics of this procedure, but it's here for transparency.
A systematic review and meta-analysis of 18 studies (963 patients, including 5 randomized controlled trials) found a pooled relative risk of response of 2.44 for TIF compared to medication or sham procedure, a statistically significant result. A prospective multicenter registry study across 9 academic and community centers found 94% of evaluable patients achieved clinical success within 1 year, with significant improvements in both symptom scores and objective measures. Durability data from a single-team series following 151 patients for up to 9 years (median follow-up 4.92 years) found sustained improvement in dysphagia and bloating scores, with no significant difference in outcomes between patients who remained off reflux medication and those who continued some level of use. A separate meta-analysis focused on atypical GERD symptoms (cough, hoarseness, throat clearing) found significant improvement at 6 and 12 months, with a pooled serious adverse event rate of just 1%. It's worth noting one smaller, earlier study (38 patients) found more modest results — hiatal hernia reduction in only 56% of patients and no significant improvement in objective acid exposure — illustrating that, as with most procedures, outcomes can vary by patient selection, technique generation, and individual case complexity, even though the larger and more rigorous body of evidence is clearly favorable.
TIF care at KAGE
TIF rebuilds the anti-reflux valve from inside the stomach with no external incision, and suits patients with objectively proven reflux and little or no hiatal hernia. Our gastroenterologists measure the hernia first, because a large one usually needs repair before any anti-reflux procedure will hold. To find out whether TIF, ARMA, or GERDx fits your anatomy, book a consultation.
Frequently asked questions
ARMA uses controlled ablation to reshape the natural valve through scarring; TIF creates a mechanical wrap using a specialized device, closer in concept to a surgical fundoplication. Both have reasonably strong evidence bases; the right choice depends on individual anatomy, discussed with your gastroenterologist.
It doesn't create the exact same anatomical result as a full surgical Nissen fundoplication, but published data shows strong, durable symptom control for appropriately selected patients, with a notably easier recovery.
Many patients are able to reduce or stop regular medication after a successful procedure, though this is assessed individually — long-term data shows good outcomes for patients both on and off medication afterward.
Generally, no — this technique is typically suited to patients with a hiatal hernia under 2cm; larger hernias are usually better addressed with a different approach, discussed during your evaluation.
Coverage varies by policy; our team can help verify your specific coverage and explain costs during consultation.
Durability has been demonstrated out to 9 years in published follow-up data from one long-term series, with sustained symptom improvement maintained over that period.
Some mild throat discomfort or difficulty swallowing for a few days is common and temporary; serious complications are uncommon, with published data showing a serious adverse event rate around just 1%.
Yes — published data shows meaningful improvement in atypical GERD symptoms such as chronic cough, hoarseness, and throat clearing as well as typical heartburn and regurgitation.
It's not typically used in children; pediatric GERD is managed differently, as covered on the Pediatric GERD & Reflux page.
Book a consultation at KAGE
Speak to a KAGE gastroenterologist about your symptoms, your diagnosis, or a second opinion.